Anavex Life Sciences Corp (AVXL)

[nidan7500]

HUH...from this article link by Penny...see post 136665...small world. Reads a lot like what has been speculated here on what is going on w/trials. Also note recent posting by a team of Israeli scientists on use of AI tools. My own thinking is this what Dr.M has been up to and is linked w/new CNS FDA trial guidance.

There are lots of good ideas on this front—including trials that are designed to adapt, which I’ve written about earlier. But this year, I believe we will have a new tool to explore in the clinical research setting: artificial intelligence. In a realm of swirling, incomprehensible big biological data—which is, perhaps, another way of thinking about the human body—the opportunity to use computer learning to better anticipate which drugs will work well (and not so well) in any one person is one we shouldn’t pass up.
As one of the world’s premier experts in clinical trials, Don Berry, told me, “The standard clinical trial is pretty much the only thing in medicine that hasn’t changed in the last 70 years.” Well, a change is gonna come.